A new observational study reported for the first time a potential link between Ozempic and Wegovy and an eye condition that can cause vision loss.

July 3, 2024 Check out STAT+

Sponsored By

EyeRounds.org and The University of Iowa Study links Ozempic to higher risk of eye condition that can cause vision loss A new study reports for the first time a potential link between Novo Nordisk's GLP-1 drugs Ozempic and Wegovy and an eye condition, NAION. By Elaine Chen After Biden debate performance, experts reflect on difference between 'normal aging' and something more Biden's health was questioned after a halting debate performance. On the issue of aging, experts try to distinguish between normal signs vs. more concerning issues. By Annalisa Merelli 'Visionary' study finds inflammation, evidence of Covid virus years after infection Researchers at UCSF have tracked the presence of the SARS-CoV-2 virus in patients' guts and elsewhere, a paper in Science Translational Medicine reports. By Isabella Cueto Justin Sullivan/Getty Images As bird flu spreads among U.S. cattle, veterinarians find themselves in a familiar position: the frontlines Rural veterinarians find themselves squeezed between helping their dairy farmer clients and working to control the growing spread of avian flu in cattle. By Andrew Joseph Opinion: President Biden needs a full medical evaluation. Voters deserve to know the results Doctor with 40 years experience in presidential health says Biden debate performance shows need for an examination: normal aging or neurological condition? By Lawrence K. Altman STAT+ | What's next for Cassava Sciences, and Cartesian Therapeutics has a novel excuse for dodgy data Plus: Cartesian Therapeutics' management team comes up with a novel excuse for dodgy data on its mRNA cell therapy for myasthenia gravis. By Adam Feuerstein Opinion: Listen: Why is eugenics still alive and well in scientific publishing? This week's episode of the First Opinion Podcast explores the racist research of Richard Lynn and why journals are reluctant to retract it. By Patrick Skerrett STAT+ | Regulating artificial intelligence doesn't have to be complicated, some experts say Experts highlighted strategies the government already uses to regulate different industries as models for writing new rules to regulate AI. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser